Grading & Level of Importance: C
Two peaks in incidence.
Rare inflammatory systemic autoimmune disease involving skin and muscle.
Aetiology & Pathogenesis
Autoimmune disease, in adults, 15% paraneoplastic (carcinomas: GI tract, lungs, breast, reproductive organs).
Signs & Symptoms
- Skin: violaceous lichenoid papules on dorsal surface of the finders (Gottron's papules), similarly coloured patches over knees, elbows and malleoli (Gottron's sign), heliotrope periorbital oedema, periungual telangiectasesiae, poikiloderma, vasculitis with necrosis.
- Muscles: necrosis of proximal muscle groups (hips, shoulders) with weakness and pain, dysphagia, dyspnoea; in children often calcinosis.
- Systemic: acute severe form with vasculitis and visceral involvement.
Dorsal aspects of fingers, knees, elbows, malleoli, face.
- Polymyositis (no skin involvement).
- Dermatomyositis sine myositis (no muscle involvement within 2 years of rash developing).
- Paraneoplastic dermatomyositis.
- Juvenile dermatomyositis.
- Dermatomyositis overlap syndromes, most commonly with progressive systemic sclerosis.
Laboratory & other workups
- ESR rate elevated, ALT, AST, LDH and muscle enzymes, especially CPK, elevated.
- ANA (40-60%), specific anti-myositis antibodies including anti-synthetase antibodies including anti-Jo-1 antibodies (may indicate a severe course with pulmonary fibrosis), ant—PL7, and others (anti-TIF1-gamma, anti-NPX2, anti-MDA-5 pulmonary interstitial disease, anti Mi-2) .
- Electromyography (EMG): polyphasic potentials.
- Directed muscle biopsy (when EMG abnormal).
Similar to lupus erythematosus, often non-specific. Muscle biopsy: muscle degeneration with lymphocytic infiltrates and obliterative vasculopathy.
Chronic. Remission in those cases where an associated malignant tumour is successfully treated.
Respiratory failure, progressive loss of muscle function, renal impairment secondary to muscle damage, calcinosis (children), vasculitis.
Clinical features (distinctive skin findings and muscle involvement), laboratory (muscle enzymes), EMG (polyphasic potentials), MRI, muscle biopsy.
Prevention & Therapy
Systemic corticosteroids, immunosuppression (cyclophosphamide, methotrexate, ciclosporin), high-dose intravenous immunoglobulins, bed rest, passive physiotherapy, photoprotection.
Further Images / DOIA
Be the first one to leave a comment!